Publish Your Articles Online
Get Recognition - International Audience
Request for an Author Account | Login | Submit Article
|HOME||FAQ||TOP AUTHORS||FORUMS||PUBLISH ARTICLE|
Transgenic Plants and Safety of Human HealthBY: SUNIL KUMAR, S.V. | Category: Agriculture | Submitted: 2012-05-07 23:20:52
Article Summary: "Now a days, the new technologies proliferated to solve many problems not only in animals, microbes etc. but also in crop improvement programmes. scientific world is moving in a fast phase to achieve required/ desired targets, in the same time, there is a need of intensive study on advers effects of these technologies on human a.."
Transgenic plants and safety of human health
Through classical plant breeding techniques, present day cultivated crops have become significantly different from their wild counterparts. Many of these crops were originally less productive and at times unsuitable for human consumption. Over the years, traditional plant breeding and selection of these crops have resulted in plants that are more productive and nutritious. The advent of GM technology has allowed further development. To date, over 30 million hectares of transgenic crops have been grown and no human health problems associated specifically with the ingestion of transgenic crops or their products have been identified. However numerous potential concerns have been raised since the development of GM technology in the early 1970s. Such concerns have focused on the potential for allergic reactions to food products, the possible introduction or increase in production of toxic compounds as a result of the GM technology, and the use of antibiotic resistance as markers in the transformation process.
Every effort should be made to avoid the introduction of known allergens into food crops. Information concerning potential allergens and natural plant toxins should be made available to researchers, industry, regulators, and the general public. In order to facilitate this effort, public databases should be developed which facilitate access of all interested parties to data.
Traditional plant breeding methods include wide crosses with closely related wild species, and may involve a long process of crossing back to the commercial parent to remove undesirable genes. A feature of GM technology is that it involves the introduction of one or at most, a few, well-defined genes rather than the introduction of whole genomes or parts of chromosomes as in traditional plant breeding. This makes toxicity testing for transgenic plants more straightforward than for conventionally produced plants with new traits, because it is much clearer what the new features are in the modified plant. On the other hand, GM technology can introduce genes from diverse organisms, some of which have little history in the food supply.
Decisions regarding safety should be based on the nature of the product, rather than on the method by which it was modified. It is important to bear in mind that many of the crop plants we use contain natural toxins and allergens. The potential for human toxicity or allergenicity should be kept under scrutiny for any novel proteins produced in plants with the potential to become part of food or feed. Health hazards from food, and how to reduce them, are an issue in all countries, quite apart from any concerns about GM technology.
Since the advent of GM technology, researchers have used antibiotic resistance genes as selective markers for the process of genetic modification. The concern has been raised that the widespread use of such genes in plants could increase the antibiotic resistance of human pathogens. Kanamycin, one of the most commonly used resistance markers for plant transformation is still used for the treatment of the following human infections: Bone, respiratory tract, skin, soft-tissue, and abdominal infections, complicated urinary tract infections, endocarditis, septicaemia, and enterococcal infections.
Scientists now have the means to remove these marker genes before a crop plant is developed for commercial use (Zubko et al. 2000). Developers should continue to move rapidly to remove all such markers from transgenic plants and to utilise alternative markers for the selection of new varieties. No definitive evidence exists that these antibiotic resistance genes cause harm to humans, but because of public concerns, all those involved in the development of transgenic plants should move quickly to eliminate these markers.
Ultimately, no credible evidence from scientists or regulatory institutions will influence popular public opinion unless there is public confidence in the institutions and mechanisms that regulate such products.
About Author / Additional Info:
Comments on this article: (0 comments so far)
• Popular Enzymes used in Genetic Engineering
• Human Sperm Created Using Embryonic Stem Cell
• Disadvantages of Gene Therapy
• Current Applications of Cold Actives Enzymes in Molecular Biology
Latest Articles in "Agriculture" category:
• Use of Biotechnology in Agriculture
• Plant Based Edible Vaccine
• Genetically Modified Food - Yes or No?
• Agricultural Biotechnology - Definition and Various Products
• Career Opportunities in Agriculture Science
• Synthetic Seed Production and Application
• Role of Biotechnology in Agriculture | Various Agricultural Technologies
• Biofortification - A Technique Used in Agriculture
• Biotechnology in Agriculture Development
• Biotechnology in Animal Feed and Feeding
• Biofertilizers: Types, Benefits and Applications
• Genetically Modified Food - Advantages and Disadvantages
• Genetically Modified Crops as Medicine
• Cryopreservation and Conservation of Plant Genetic Material
• Biotechnology and the Coconut
• Biotechnology in Rice Farming
• Bt Corn: Method, Mode of Action and Benefits
• Safe Insecticides For the Environment
• Plant Growth Promoting Substances
Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms.
Copyright © 2010 biotecharticles.com - Do not copy articles from this website.
ARTICLE CATEGORIES :
| Disclaimer/Privacy/TOS | Submission Guidelines | Contact Us